U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing 
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
Itochu Offers $1.56 Billion to Privatize Dentsu Soken 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’ 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
Amazon Secures 200 MW Wind Power Deals in Sweden 
Jefferies Names AMEC Top China Semiconductor Equipment Pick 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Add as a preferred source on Google
SAN CLEMENTE, Calif., April 12, 2018 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of its first quarter 2018 earnings release and conference call.
The Company will release its first quarter 2018 results on Wednesday, May 9th, 2018 at approximately 4:00 p.m. EST (1:00 p.m. PST) and will be conducting a conference call concerning those results at 4:30 p.m. EST (1:30 p.m. PST) on Wednesday, May 9th, 2018. The call can be accessed at (800) 936-9761, conference ID 3029969. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical, Inc.
ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical devices used in vascular therapy, and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical, Inc. can be found at www.icumed.com.
CONTACT:
ICU Medical, Inc.
Scott Lamb, Chief Financial Officer
(949) 366-4227
ICR, Inc.
John Mills, Partner
(646) 277-1254
